We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
MHRA is seeking views on the reclassification of Galpharm Period Pain Relief 250mg Gastro-Resistant Tablets from pharmacy to general sale list.
The MHRA is seeking views on the reclassification from pharmacy to general sale list of Nurofen Express 400mg Oral Powder.
The MHRA is seeking views on the proposal on the introduction of tell-and-do variations for a specific subset of parallel import licences.
The MHRA is undertaking a public consultation on the continued availability of diclofenac as a Pharmacy (P) medicine.
The Department of Health and the MHRA are seeking views on this proposal by the European Commission.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
The MHRA is undertaking a public consultation on proposals to end the 'sell through' of unlicensed herbal remedies legally on market at April 2011.
This consultation (ARM83) welcomes views on proposals to classify Pirinase Hayfever Relief for Adults 0.05% Nasal Spray as a general sales list (GSL) product in the UK.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).